Dr. David Wang is a structural interventional cardiologist at UCSF. He specializes in structural heart interventions, including transcatheter repair and replacement of all heart valves (TAVR, mitral and tricuspid TEER, TMVR, TTVR, TPVR). He cares for patients with valvular heart disease, advanced heart failure, and congenital heart disease.

He earned his medical degree from Harvard Medical School. He completed medicine residency at Brigham and Woman’s Hospital/Harvard and then completed fellowships in cardiology and interventional cardiology (coronary and structural) at Stanford University. He then completed an additional year of advanced structural and congenital heart interventional training at UCSF. He has received awards throughout training for clinical excellence and teaching. He is an investigator on several national clinical trials. He has published multiple peer reviewed scientific articles and reviews and presented on complex transcatheter interventions at several national conferences.

He has dedicated his career and training to providing the best care to his patients through technical expertise and a collaborative approach with his patients and their families. His clinical interests include
1. Valvular heart disease - transcatheter valve repair and replacement (TAVR, mitral and tricuspid TEER, TMVR, TTVR, TPVR)
2. Balloon pulmonary angioplasty (BPA) for chronic thrombo embolic pulmonary hypertension (CTEPH) and pulmonary venous interventions
3. Interventional heart failure therapies and clinical trials
4. Percutaneous removal/aspiration of endocarditis and cardiac masses
5. Patent foramen ovale (PFO)/ atrial septal defect (ASD) closure